Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs BAFNA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS BAFNA PHARMA RAYMED LABS/
BAFNA PHARMA
 
P/E (TTM) x -7.1 16.1 - View Chart
P/BV x - 2.5 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 RAYMED LABS   BAFNA PHARMA
EQUITY SHARE DATA
    RAYMED LABS
Mar-23
BAFNA PHARMA
Mar-23
RAYMED LABS/
BAFNA PHARMA
5-Yr Chart
Click to enlarge
High Rs2141 1.4%   
Low Rs179 1.9%   
Sales per share (Unadj.) Rs048.8 0.0%  
Earnings per share (Unadj.) Rs-0.44.8 -8.4%  
Cash flow per share (Unadj.) Rs-0.47.0 -5.5%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-5.431.0 -17.4%  
Shares outstanding (eoy) m4.2723.66 18.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x02.3-  
Avg P/E ratio x-4.422.9 -19.3%  
P/CF ratio (eoy) x-4.615.6 -29.3%  
Price / Book Value ratio x-0.33.5 -9.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m82,596 0.3%   
No. of employees `000NANA-   
Total wages/salary Rs m0159 0.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m01,154 0.0%  
Other income Rs m033 0.6%   
Total revenues Rs m01,186 0.0%   
Gross profit Rs m-2157 -1.2%  
Depreciation Rs m053 0.1%   
Interest Rs m020 0.0%   
Profit before tax Rs m-2116 -1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m03 0.0%   
Profit after tax Rs m-2113 -1.5%  
Gross profit margin %013.6- 
Effective tax rate %02.4 -0.0%   
Net profit margin %09.8- 
BALANCE SHEET DATA
Current assets Rs m0873 0.0%   
Current liabilities Rs m1465 0.2%   
Net working cap to sales %035.4- 
Current ratio x0.11.9 3.0%  
Inventory Days Days02- 
Debtors Days Days01,302- 
Net fixed assets Rs m2423 0.4%   
Share capital Rs m43237 18.1%   
"Free" reserves Rs m-66498 -13.2%   
Net worth Rs m-23735 -3.1%   
Long term debt Rs m084 0.0%   
Total assets Rs m21,296 0.1%  
Interest coverage x06.7-  
Debt to equity ratio x00.1 -0.0%  
Sales to assets ratio x00.9 0.0%   
Return on assets %-109.510.3 -1,060.7%  
Return on equity %7.415.4 48.0%  
Return on capital %7.416.7 44.4%  
Exports to sales %00-  
Imports to sales %07.9-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA91 0.0%   
Fx inflow Rs m0885 0.0%   
Fx outflow Rs m091 0.0%   
Net fx Rs m0794 0.0%   
CASH FLOW
From Operations Rs m-250 -3.3%  
From Investments Rs m2-75 -2.2%  
From Financial Activity Rs mNA102 0.0%  
Net Cashflow Rs m076 -0.0%  

Share Holding

Indian Promoters % 28.4 88.4 32.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 11.6 619.2%  
Shareholders   1,498 7,367 20.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RAYMED LABS. vs BAFNA PHARM.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RAYMED LABS. vs BAFNA PHARM. Share Price Performance

Period RAYMED LABS. BAFNA PHARM. S&P BSE HEALTHCARE
1-Day 0.00% -1.07% 1.18%
1-Month 3.32% -11.71% -0.75%
1-Year 6.86% -4.18% 61.82%
3-Year CAGR 31.90% -19.05% 18.16%
5-Year CAGR -1.90% 47.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the RAYMED LABS. share price and the BAFNA PHARM. share price.

Moving on to shareholding structures...

The promoters of RAYMED LABS. hold a 28.4% stake in the company. In case of BAFNA PHARM. the stake stands at 88.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RAYMED LABS. and the shareholding pattern of BAFNA PHARM..

Finally, a word on dividends...

In the most recent financial year, RAYMED LABS. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

BAFNA PHARM. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of RAYMED LABS., and the dividend history of BAFNA PHARM..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.